Cancer Global Summit-CGS 2026

Molecular imaging is a strong diagnostic and management tool in cancer, enabling clinicians to image tumors at the level of molecules and cells. The session "Molecular Imaging" emphasizes the most recent advances in imaging technologies for increased early detection, treatment planning, and surveillance of cancer development.".

In contrast to conventional imaging techniques, molecular imaging reveals advanced information about tumor biology through the identification of specific molecular targets, metabolism, and cellular alterations. Methods like PET, SPECT, MRI, and optical imaging are integrated with targeted contrast agents or tracers to visualize cancer with high precision and sensitivity. These modalities allow clinicians to differentiate benign and malignant tissue, evaluate tumor heterogeneity, and monitor treatment response over time.

This session also delves into the potential of molecular imaging in individualized medicine. Through the depiction of tumors with precise molecular details, imaging supports targeted treatments, maximizes treatment regimens, and forecasts results. New breakthroughs, such as the use of AI-enhanced image analysis and emerging radiotracers, are broadening the application of molecular imaging and enhancing clinical choices.

Delegates will have a thorough grasp of the principles of molecular imaging, its practical applications, and its emerging trends in oncology. This session highlights how molecular imaging is redesigning cancer diagnosis for a brighter future, facilitating earlier diagnosis, targeted treatment guidance, and better patient care.